All News #Library
Biotech
Ensysce Gets IRB Nod for Final Phase of PF614-MPAR-102
16 Apr 2026 //
PHARMIWEB
Ensysce Biosciences Announces First MPAR Publication
03 Mar 2026 //
PHARMIWEB
Ensysce Biosciences Updates PF614 Phase 3 Enrollment
28 Jan 2026 //
PHARMIWEB
Ensysce Biosciences Starts Key Phase 3 Trial For PF614, Opioid
09 Dec 2025 //
PHARMIWEB
Ensysce Biosciences Enhances Patent Protection For MPAR(R)
02 Dec 2025 //
PHARMIWEB
Ensysce Biosciences Gets FDA Nod On PF614 Manufacturing Approach
20 Nov 2025 //
PHARMIWEB
Ensysce Bio Secures $4M, Unlocking $20M For Pain Programs
17 Nov 2025 //
PHARMIWEB
Ensysce Biosciences Reports Third Quarter 2025 Financial Results
14 Nov 2025 //
PHARMIWEB
Ensysce Biosciences Unveils Painweek 2025 Symposium Highlights
10 Oct 2025 //
PHARMIWEB
Ensysce Biosciences Reports 2024 Financial Results
10 Mar 2025 //
ACCESSWIRE

Market Place
Sourcing Support